Resistance to alkylating agents and cisplatin: Insights from ovarian carcinoma model systems
- 1 January 1990
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 48 (1), 19-27
- https://doi.org/10.1016/0163-7258(90)90015-t
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)Biochemistry, 1988
- Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexesChemico-Biological Interactions, 1987
- Domainal evolution of a prokaryotic DNA repair protein and its relationship to active-transport proteinsNature, 1986
- The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitroBritish Journal of Cancer, 1986
- Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNABiochemistry, 1986
- Inhibition of DNA repair by trifluoperazineBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1985
- Potentiation of Bleomycin Lethality by Anticalmodulin Drugs: A Role for Calmodulin in DNA RepairScience, 1984
- Membrane transport, sulfhydryl levels and DNA cross-linking in Chinese hamster ovary cell mutants sensitive and resistant to melphalanBiochemical Pharmacology, 1983
- Carrier-dependent and carrier-independent transport of anti-cancer alkylating agentsNature, 1981
- Induction and Repair of Single-strand DNA Breaks after X-irradiation of Human Fibroblasts Deficient in GlutathioneInternational Journal of Radiation Biology, 1981